Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintaining Nonsmoking in Older Smokers
NCT00086385Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Sep 2001
- Primary completion
- Mar 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nicotine polacrilex in Tobacco Use Disorder (TUD) (4 arms), sponsored by University of California, San Francisco. Primary endpoint: Participants Abstinent From Cigarettes at 2 years. Started Sep 2001; status: completed.
02
Drugs
nicotine polacrilex
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00086385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086385.